MPN-136 Pelabresib Plus Ruxolitinib Combination Therapy in JAK Inhibitor-Naïve Patients With Myelofibrosis in the Phase 3 MANIFEST-2 Study: Preliminary Evidence of Bone Marrow Recovery
Year: 2024
Type: conference-abstract
Authors: John Mascarenhas, Raajit K. Rampal, Alessandro M. Vannucchi, Vikas Gupta, Stephen T. Oh, Andrew T. Kuykendall, Ruben Mesa, Jean-Jacques Kiladjian, Moshe Talpaz, Marina Kremyanskaya, Joseph Scandura, Tabea Kräft, Jean-Pierre Eliane, Tzuu-Wang Chang, Jike Cui, Christian Kuffer, Rainer Boxhammer, Claire Harrison
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4401877343